The Journal of Experimental Medicine
3rd Skeletal Biology and Medicine Symposium
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published online 30 April 2001.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guermonprez, P.
Right arrow Articles by Leclerc, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guermonprez, P.
Right arrow Articles by Leclerc, C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
© The Rockefeller University Press, 0022-1007/2001/5/1035/ $5.00
The Journal of Experimental Medicine, Volume 193, Number 9, May 7, 2001 1035-1044

Original Article

The Adenylate Cyclase Toxin of Bordetella pertussis Binds to Target Cells via the {alpha}Mß2 Integrin (CD11b/CD18)

Pierre Guermonpreza, Nadia Khelefb, Eric Blouind, Philippe Rieud, Paola Ricciardi-Castagnolie, Nicole Guisob, Daniel Ladantc, and Claude Leclerca
a Unit of Biology of Immune Regulations, Institut Pasteur,
b Unit of Bordetella, Institut Pasteur,
c Unit of Cellular Biochemistry, Institut Pasteur,
d Unit 507, Institut National de la Santé et de la Recherche Medicale (INSERM), Department of Nephrology, Necker Hospital, Paris 75015, France
e Department of Biotechnology and Bioscience, University of Milano-Bicocca, Milano 20126, Italy

Correspondence to: Claude Leclerc, Unit of Biology of Immune Regulation, Institut Pasteur, 25 Rue du Dr Roux, 75724 Paris cedex 15, France. Tel:33-1-4568-8618 Fax:33-1-4568-8540 E-mail:cleclerc{at}pasteur.fr.

The adenylate cyclase toxin (CyaA) of Bordetella pertussis is a major virulence factor required for the early phases of lung colonization. It can invade eukaryotic cells where, upon activation by endogenous calmodulin, it catalyzes the formation of unregulated cAMP levels. CyaA intoxication leads to evident toxic effects on macrophages and neutrophils. Here, we demonstrate that CyaA uses the {alpha}Mß2 integrin (CD11b/CD18) as a cell receptor. Indeed, the saturable binding of CyaA to the surface of various hematopoietic cell lines correlated with the presence of the {alpha}Mß2 integrin on these cells. Moreover, binding of CyaA to various murine cell lines and human neutrophils was specifically blocked by anti-CD11b monoclonal antibodies. The increase of intracellular cAMP level and cell death triggered by CyaA intoxication was also specifically blocked by anti-CD11b monoclonal antibodies. In addition, CyaA bound efficiently and triggered intracellular cAMP increase and cell death in Chinese hamster ovary cells transfected with {alpha}Mß2 (CD11b/CD18) but not in cells transfected with the vector alone or with the {alpha}Xß2 (CD11c/CD18) integrin. Thus, the cellular distribution of CD11b, mostly on neutrophils, macrophages, and dendritic and natural killer cells, supports a role for CyaA in disrupting the early, innate antibacterial immune response.

Key Words: Bordetella, adenylate cyclase, integrin, CD11b, toxin


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS